CAS RN: 756839-14-2
1H-Indazol-5-ol, 1-methyl- (9CI)
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250603
50mg / 250mg / 1g / 5g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 756839-14-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Shanghai
Inquiry
756839-14-2 / 1-methylindazol-5-ol
Standard CAS: 756839-14-2
Multi CAS: Yes
Basic Information
copy
CAS
756839-14-2 copy
Multi CAS
Yes copy
Molecular Formula
C8H8N2O copy
Molecular Weight
148.160000 copy
Exact Mass
148.063663 copy
InChI
InChI=1S/C8H8N2O/c1-10-8-3-2-7(11)4-6(8)5-9-10/h2-5,11H,1H3 copy
InChIKey
NNIUCKWMURTFEZ-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
9 copy
Fraction Csp3
0.12 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
42.38 copy
TPSA
38.05 copy
LogP / Solubility
WLOGP
1.28 copy
MLOGP
1.12 copy
XLogP3
1.2 copy
Consensus LogP
1.2 copy
Log S (ESOL)
-2.17 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.7 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.68 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.72 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy